The excretion mechanism of the spin label proxyl carboxylic acid (PCA) from the rat monitored by X-band ESR and PEDRI

Magnetic Resonance in Medicine

Volumn 37, Issue 4, 1997, Pages 552-558

  Seimenis, Ioannis ^a   Foster, Margaret A ^a   Lurie, David J ^a   Hutchison, James M S ^a   Whiting, Paul H ^a   Payne, Simon ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

ESR; PCA; PEDRI; probenecid

Indexed keywords

CARBOXYLIC ACIDS; FREE RADICALS; METABOLISM; PARAMAGNETIC RESONANCE; RATS;

BOVINE SERUM ALBUMINS; HYDROPHILIC SITES; METABOLIC REDUCTION; NITROXIDE FREE RADICALS; PEDRI; PROBENECID; PROTON ELECTRON DOUBLE RESONANCE IMAGING; RENAL TISSUE;

ELECTRON SPIN RESONANCE SPECTROSCOPY;

BOVINE SERUM ALBUMIN; CARBOXYLIC ACID DERIVATIVE; FREE RADICAL; NITROXIDE DERIVATIVE; PROBENECID; PROXYL CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; ELECTRON SPIN RESONANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE EXCRETION; LIVER METABOLISM; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SPIN LABELING;

EID: 0030972566     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910370413     Document Type: Article

References (35)

1. G. Bacic, M. J. Nilges, R. L. Magin, T. Walczac, H. M. Swartz, In vivo localised ESR spoctroscopy reflecting metabolism. Magn. Reson. Med. 10, 266-272 (1989).
2. V. Quaresima, M. Alecci, M. Ferrari, A. Sotgiu, Whole rat EPR imaging of a nitroxide free radical by a radiofrequency spectrometer. Biochem. Biophys. Res. Commun. 183, 829-835 (1992).
3. M. Alecci, M. Ferrari, V. Quaresima, A. Sotgiu, C. L. Ursini, Simultaneous 280 MHz EPR imaging of rat organs during nitroxide free radical clearance. Biophys. J. 67, 1274-1279 (1994).
4. R. C. Brasch, D. A. London, C. E. Wesbey, T. N. Tozer, D. E. Nitecki, R. D. Williams, J. Doemeny, L. D. Tuck, D. P. Lallemand, Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 147, 773-779. (1983).
5. R. C. Brasch, D. E. Nitecki, M. Brant-Zawadzki, D. R. Enzmann, G. E. Wesbey, T. N. Tozer, L. D. Tuck, C. E. Cann, J. R. Fike, P. Sheldon, Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. AJNR 4, 1035-1039 (1983).
6. R. L. Ehman, G. E. Wesbey, K. L. Moon, R. D. Williams, M. T. McNamara, W. R. Couet T. N. Tozer, R. C. Brasch, Enhanced MRI of tumors utilizing a new nitroxyl spin-label contrast agent. Magn. Reson. Imaging. 3, 89-97 (1985).
7. H. M. Swartz, in "Advances in Magnetic Resonance Imaging" (E. Feig, Ed.), vol. 1, p. 49, Ablex Publishing Corporation, Norwood, New Jersey, 1989.
8. H. M. Swartz, K. Chen, M. Pals, M. Sentjurc, P. D. I. I. Morse, Hypoxia sensitive NMR contrast agents. Magn. Reson. Med. 3, 169-174 (1986).
9. M. A. Pals, H. M. Swartz, Oxygen dependent metabolism of potential MR contrast agents. Invest. Radiol. 22, 497-501 (1987).
10. D. Grucker, T. Guiberteau, B. Eclancher, J. Chambron, R. Chiarelli, A. Rassat, G. Subra, B. Gallez, Dynamic nuclear polarization with nitroxides dissolved in biological fluids. J. Magn. Reson. B106, 101-109, (1995).
11. D. J. Lurie, D. M. Bussell, L. H. Bell, J. R. Mallard, Proton electron Double resonance imaging of free radical solutions. J. Magn. Reson. 76, 366-370 (1988).
12. D. J. Lurie, I. Nicholson, M. A. Foster, J. R. Mallard, Free radicals imaged in vivo in the rat by using proton-electron double-resonance imaging. Phil. Trans. R. Soc. Lond. A333, 453-456, (1990).
13. W. R. Couet, U. G. Eriksson, T. N. Tozer, L. D. Tuck, G. E. Wesbey, D. Nitecki, R. C. Brasch, Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imaging. Pharm. Res. 5, 203-209 (1984).
14. L. K. Griffeth, G. M. Rosen, E. J. Raukman, B. P. Drayer, Pharmacokinetics of nitroxide NMR contrast agents. Invest. Radiol. 19, 553-562, (1984).
15. J. F. W. Keana, S. Pou, G. M. Rosen, Nitroxides as potential contrast enhancing agents for MRI application: Influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn. Reson. Med. 5, 525-536, (1987).
16. V. Afzal, R. C. Brasch, D. E. Nitecki, S. Wolff, Nitroxyl spin label contrast enhancers for magnetic resonance imaging: Studies of acute toxicity and mutagenesis. Invest. Radiol. 19, 549-552 (1984).
17. G. Sosnovsky, A critical evaluation of the present status of toxicity of aminoxyl radicals. J. Pharm. Sci. 81, 496-499, (1992).
18. I. M. Weiner, J. A. Washington, G. H. Mudge, On the mechanism of action of probenecid on renal tubular secretion. Bull. Johns Hopkins Hosp. 106, 333-346, (1960).
19. I. M. Weiner, in "Goodman and Gilman's the pharmacological basis of therapeutics" (A. Goodman Gilman, T. W. Rall, A. S. Nies, P. Taylor, Eds.), p. 743, Pergamon, New York, 1990.
20. J. D. Morrisett, H. J. Pownall, A. M. J. Cotto, Bovine serum albumin: study of the fatty acid and steroid binding sites using spin-labelled lipids. J. Biol. Chem. 250, 2487-2494, (1975).
21. J. D. Holtzman. "Spin labeling in Pharmacology," Academic Press, Orlando, 1984.
22. J. R. Mallard, J. M. S. Hutchison, W. A. Edelstein, C. R. Ling, M. A. Foster, G. Johnson, In vivo NMR imaging in medicine: the Aberdeen approach, both physical and biological. Phil. Trans. R. Soc. Lond. B289, 519-533, (1980).
23. D. W. Alderman, D. M. Grant, An efficient decoupler coil design which reduces heating in conductive samples in superconducting spectometers J. Magn. Reson. 36, 447-451, (1979).
24. I. Nicholson, "Proton Electron Double Resonance Imaging of free radicals," Ph.D. Thesis, University of Aberdeen, Aberdeen, (United) Kingdom, 1992.
25. P. A. Bottomley, T. H. Foster, R. E. Argersinger, L. M. Pfeifer, A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: Dependence on tissue type, NMR frequency, temperature, species, excision and age. Med. Phys. 11, 425-448 (1984).
26. D. R. Sadler, "Numerical Methods for Nonlinear Regression," University of Queensland Press, St. Lucia, 1975.
27. P. Fossati, L. Prencipe, G. Berti, Use of 3 5-dichloro-2-hydroxybenzenesulfonic acid/4- aminophenazone chromogenic system in direct enzymic assay of uric acid. Clin. Chem. 26, 227-231 (1980).
28. W. P. Raab, C. M. Moerth, Probenecid and the rat kidney: investigations by renal enzyme excretion technique. Int. J. Clin. Pharm. Biopharm. 13, 120-122 (1976).
29. R. E. Notari, "Biopharmaceutics and Clinical Pharmacokinetics," Marcel Dekker, New York, 1980.
30. J. H. Noggle, "Practical Curve Fitting and Data Analysis," PTR Prentice Hall, Chichester, New Jersey, 1993.
31. L. Z. Benet, J. R. Mitchell, L. B. Sheiner, in "Goodman and Gilman's the Pharmacological Basis of Therapeutics" (A. Goodman Gilman, T. W. Rall, A. S. Nies, P. Taylor, Eds.), p. 3, Pergamon Press, New York, 1990.
32. W. C. Bowman, M. J. Rand, "Textbook of Pharmacology," Blackwell Publications, Oxford, 1980.
33. I. M. Weiner, in "Goodman and Gilman's the Pharmacological Basis of Therapeutics" (A. Goodman Gilman, T. W. Rall, A. S. Nies, P. Taylor, Eds.), p. 713, Pergamon, New York, 1990.
34. T. Terasaki, I. Tamai, K. Takanosu, E. Nakashima, A. Tsuji, Kinetic evidence for a common transport route of benzylpenicillin and probenecid by freshly prepared hepatocytes in rats. Influence of sodium ion, organic anions, amino acids and peptides on benzylpenicillin uptake. J. Pharmacobio-Dyn. 9, 18-28, (1986).
35. M. A. Foster, R. Partridge, I. Seimenis, D. J. Lurie, Passage of a nitroxide spin-label through rat liver: Quantitative inter-relationship of ESR and PEDRI observations, in "Proc., SMR, 3rd Annual Meeting, Nice, 1995." p. 1213.